Atropine sulfate 0.025 mg / hyoscyamine sulfate 0.13 mg / PHENobarbital 16.2 mg / scopolamine HBr 0.0074 mg Oral Tablet
RxNorm 1048085
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1048085 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: atropine sulfate 0.025 mg / hyoscyamine sulfate 0.13 mg / PHENobarbital 16.2 mg / scopolamine HBr 0.0074 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Atropine sulfate 0.025 mg / hyoscyamine sulfate 0.13 mg / phenobarbital 16.2 mg / scopolamine hydrobromide 0.0074 mg Oral Tablet
(Atom ID: 12325321)
PSN
Prescribable Name (PSN):
Atropine sulfate 0.025 mg / hyoscyamine sulfate 0.13 mg / PHENobarbital 16.2 mg / scopolamine HBr 0.0074 mg Oral Tablet
(Atom ID: 6364632)
TMSY